Clinical evaluation and treatment of tauopathic syndromes remain a challenge. There is a
growing interest in theories concerning their possible associations with metabolic diseases …

Metabolic Syndrome (MetS) is a complex, multifactorial condition characterized by risk
factors such as abdominal obesity, insulin resistance, dyslipidemia and hypertension, which …

Type 2 diabetes, prediabetes, and insulin resistance (IR) are widespread yet often
undetected in their early stages, contributing to a silent epidemic. Metabolic Syndrome …

Metabolic syndrome (MetS), comprising obesity, insulin resistance, hypertension, and
dyslipidemia, increases the risk of type II diabetes mellitus and cardiovascular disease. This …

Abstract The American Heart Association recently defined the complex interactions among
the cardiovascular, renal, and metabolic systems as CKM syndrome. To promote better …

Metabolic syndrome is a multifaceted metabolic disorder characterized by a constellation of
interconnected risk factors, including insulin resistance, abdominal obesity, dyslipidemia …

Metabolic syndrome (MetS) is associated with an increased risk of developing
cardiovascular disease, diabetes, and other health complications; thus, the increase in its …

Background Observational studies and clinical trials have implicated polyunsaturated fatty
acids (PUFAs) in potentially safeguarding against diabetic microvascular complication …

Background Metabolic syndrome (MetS) is a global health concern, and it is particularly
harmful to middle-aged and elderly individuals. Life Element Eight (LE8), a measure to …

The expression of BDNF in both neuronal and non-neuronal cells is influenced by various
stimuli, including prenatal developmental factors and postnatal conditions such as …